Providers WA

06/22/22 Health Advisory: COVID-19 Vaccine for Children as Young as 6 Months

Two babies in pool using pool floats

Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup concluded COVID-19 vaccines are safe and effective for children as young as 6 months. Available to children 6 months to 4 years old: Pfizer COVID-19 vaccine, in a 3-dose primary series. Be sure to review dosage and vial labeling 06/22/22 Health Advisory: COVID-19 Vaccine for Children as Young as 6 Months

05/27/22 Health Advisory: COVID-19 rebound after Paxlovid treatment

close up of a line of prescription pill bottles

Requested actions Be aware, Centers for Disease Control and Prevention (CDC) issued a health advisory about COVID-19 rebound after Paxlovid treatment. Continue to offer Paxlovid for early-stage treatment of mild to moderate COVID-19 in people at high risk of severe disease. Be aware, providers have reported COVID-19 rebound—recurring symptoms or a new positive test after 05/27/22 Health Advisory: COVID-19 rebound after Paxlovid treatment

05/20/22 Health Advisory: CDC Recommends 5-11 year olds get a Pfizer COVID-19 Booster

three kids looking down at camera

Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend children 5–11 years old get a booster dose of Pfizer COVID-19 vaccine 5 months after completing their primary series. The recommendation came after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer 05/20/22 Health Advisory: CDC Recommends 5-11 year olds get a Pfizer COVID-19 Booster

04/27/22 Health Advisory: CDC Treatment Updates and ACIP expands COVID-19 vaccine second booster dose eligibility

Ariel shot of someone taking notes or completing paperwork

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use 04/27/22 Health Advisory: CDC Treatment Updates and ACIP expands COVID-19 vaccine second booster dose eligibility

12/13/21: Health Advisory: COVID-19 Updates for Providers

Black hands holding face mask

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech 12/13/21: Health Advisory: COVID-19 Updates for Providers

10/1/21 Health Advisory: COVID-19 Updates for Providers

Pregnant woman talking to doctor while looking at a clipboard

Requested actions Promote COVID-19 vaccine among people who are pregnant, lactating or who may become pregnant. Only 31% of pregnant people in the U.S. are fully vaccinated. In 2021, 97% of pregnant people hospitalized for COVID-19 illness or labor and delivery with active infection were unvaccinated. Educate patients on the safety and effectiveness of COVID-19 10/1/21 Health Advisory: COVID-19 Updates for Providers

9/15/21 – Health Advisory: Be vigilant for measles and polio among newly arrived refugees from Afghanistan

Doctor in white jacket writing on clipboard

Requested actions Be vigilant for measles and polio in patients with compatible symptoms, especially among people who recently arrived from countries where measles and polio circulate, including Afghanistan. Be aware of immunization recommendations for people arriving from Afghanistan. Immediately report suspected cases of measles or polio. Background Afghanistan ranks seventh in the world for measles 9/15/21 – Health Advisory: Be vigilant for measles and polio among newly arrived refugees from Afghanistan

8/16/21 – Health Advisory: COVID-19 Vaccine Update for Clinicians

blurry doctor office

Requested actions Be aware, the U.S. Food and Drug Administration (FDA) amended its emergency use authorizations (EUAs) for Pfizer and Moderna COVID-19 vaccines to allow an additional (third) dose for certain immunocompromised people. Be aware, the Advisory Committee on Immunization Practices (ACIP) authorized an additional (third) dose of Pfizer and Moderna COVID-19 vaccines under a revised EUA for certain people who 8/16/21 – Health Advisory: COVID-19 Vaccine Update for Clinicians

7/26/21 Health Advisory: COVID-19 Updates for Providers

blurry doctor's waiting room

Requested actions Be aware, Washington State Department of Health (DOH) issued an alert of high rates of unaddressed behavioral health concerns among healthcare and public health workers. Engage in a PsySTART-Responder assessment, an evidence-based method to gain awareness of one’s own psychological risk and develop individualized coping plans. To create a PsySTART account, email DOH-BHadmin@doh.wa.gov with subject 7/26/21 Health Advisory: COVID-19 Updates for Providers

7/19/21 Health Advisory: COVID-19 Updates for Providers

doctor writing on an ipad

Requested actions Be aware the U.S. Food and Drug Administration (FDA) updated the Johnson & Johnson/Janssen (J&J) COVID-19 vaccine Emergency Use Authorization (EUA) fact sheets to include possible risks of thrombosis with thrombocytopenia and Guillain-Barré Syndrome (GBS) following vaccination: Fact sheet for healthcare providers. Fact sheet for patients. Be aware the FDA extended the shelf life of J&J 7/19/21 Health Advisory: COVID-19 Updates for Providers